Princeton Junction, NJ, United States of America

Amedeo A Failli

This inventor holds 79 USPTO granted patents, primarily in Vasopressin Agonists (CPC class 5404). Top assignees: American Home Products Corporation, Wyeth, American Home Products Company. Active years: 1989-2010.

USPTO Granted Patents = 79

% Patents Active = 70.9

Average Co-Inventor Count = 3.2

ph-index = 25

Forward Citations = 2,498(Granted Patents)

Forward Citations (Not Self Cited) = 2,413(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Princeton Juncton, NJ (US) (1991)
Princeton, NJ (US) (1994 - 2004)
Princeton Junction, NJ (US) (1989 - 2010)

Company Filing History:

50 out of 1,567

American Home Products Corporation

American Home Products Company

patent

4. 2 out of 834,411

Other

patents

Years Active: 1989-2010

Loading Chart...

Areas of Expertise:

Vasopressin Agonists

Tocolytic Oxytocin Receptor Antagonists

Pyrrolobenzodiazepines

Tricyclic Diazepines

Arylthiophene

Antiatherosclerotic Agents

Cyclohexylphenyl

Biphenyl

Pyridobenzodiazepine

Carbazole

Indole Inhibitors

Effector Proteins

79 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7691848 - Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists (2010-04-06),

2. 7687623 - Pyrrolobenzodiazepines and heterocyclic carboxamide derivatives as follicle stimulating hormone receptor (FSH-R) antagonists (2010-03-30),

3. 7678787 - Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists (2010-03-16),

4. 7465722 - Biphenyl vasopressin agonists (2008-12-16),

5. 7378427 - Processes for preparing 6-alkyl-5-arylsulfonyl-dihydrophenanthridines (2008-05-27),

6. 7329653 - Cyclohexylphenyl vasopressin agonists (2008-02-12),

7. 7326700 - Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists (2008-02-05),

8. 7297704 - Cycloalkyfused indole, benzothiophene, benzofuran and idene derivatives (2007-11-20),

9. 7223752 - Biphenyl vasopressin agonists (2007-05-29),

10. 7202239 - Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists (2007-04-10),

11. 7153849 - Antidepressant arylpiperazine derivatives of hetrocycle-fused benzodioxans (2006-12-26),

12. 7109193 - Tricyclic diazepines tocolytic oxytocin receptor antagonists (2006-09-19),

13. 7064120 - Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists (2006-06-20),

14. 7053083 - Cyclohexylphenyl vasopressin agonists (2006-05-30),

15. 7022699 - Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators (2006-04-04),

Title: Amedeo A Failli: Pioneering Inventor from Princeton Junction, NJ

Introduction:

Amedeo A Failli, a prolific inventor hailing from Princeton Junction, NJ, has made significant contributions to the field of pharmaceuticals with a remarkable track record of 79 patents to his name.

Latest Patents:

Among his latest patents is the groundbreaking invention of Pyrrolobenzodiazepine arylcarboxamides, which act as follicle stimulating hormone receptor antagonists. Additionally, Failli's work on Pyrrolobenzodiazepines and heterocyclic carboxamide derivatives as FSH-R antagonists showcases his innovative approach to pharmaceutical research.

Career Highlights:

Failli's expertise has been honed through his tenure at esteemed companies such as American Home Products Corporation and Wyeth. His dedication to pioneering research and development has led to the successful filing of numerous patents, solidifying his reputation as a visionary in the industry.

Collaborations:

Throughout his career, Failli has collaborated with notable peers in the field, including Robert J Steffan and Thomas Joseph Caggiano. Together, they have worked on cutting-edge projects that have pushed the boundaries of pharmaceutical innovation.

Conclusion:

In conclusion, Amedeo A Failli's exceptional talent and unwavering commitment to advancing pharmaceutical sciences have established him as a trailblazer in the field of inventions. His groundbreaking patents and successful collaborations underscore his significant impact in shaping the future of pharmaceutical research.